HealthTiziana’s experimental MS treatment meets main goals in mid-stage study
Tiziana Life Sciences said on Monday that its experimental therapy for a progressive form of multiple sclerosis with no approved treatments lowered brain inflammation and had a favorable safety profile in a mid-stage trial.
R
Reuters★★☆☆☆2026-11-02 18:15Original
Tiziana’s experimental MS treatment meets main goals in mid-stage study
Health